In humans, healthy individuals with higher circulating leptin levels are often accompanied by lower insulin sensitivity independent of adiposity, suggesting that hyperleptinemia could be a compensatory response to insulin resistance (Chiriaco et al. 2024), which might lead to more adverse effects on metabolic outcomes (Zhao et al. 2019). The gene discussed is LEP; the disease is Insulin resistance.